BD ArcticSun™ 5000 Targeted Temperature Management System (TTM)
BD ArcticSun™ 5000 Targeted Temperature Management (TTM) System
BD ArcticSun™ 5000 is a targeted temperature management (TTM) system that non-invasively monitors and controls the patient's body temperature through ArcticGel™ pads. The clinician sets the target temperature, and the device automatically adjusts the temperature of the water circulating in the pads according to the patient's measured temperature. It is used in adults and in pediatric patients of all ages. Prizma-Med is the exclusive Türkiye distributor and the sole authorized service provider for BD ArcticSun™ systems, providing sales, training and service support.
This page is intended for healthcare professionals. Treatment decisions and targets are determined by the physician; please refer to the product's instructions for use for detailed information.
Why does TTM matter?
In patients who survive cardiac arrest, neurological recovery is the most important factor determining outcome. Each 1 °C fall in body temperature reduces cerebral metabolism by approximately 6–10%, while fever may worsen brain injury. For this reason, the AHA and ERC-ESICM 2025 guidelines recommend planned temperature control and fever prevention in comatose patients after cardiac arrest. Neonatal hypoxic-ischemic encephalopathy (HIE) is also an established indication for therapeutic hypothermia. Four conditions are required for effectiveness: starting early, keeping the patient consistently within the target range, rewarming slowly and in a controlled manner, and managing side effects such as shivering.
How does it work?
- Cooling: ArcticGel™ pads are applied to the patient's torso and thighs. Water circulating in the pads brings the patient rapidly to the target temperature.
- Maintenance: The device continuously measures the patient's temperature, automatically adjusts the water temperature and keeps the patient at target.
- Controlled rewarming: The patient is returned to normothermia slowly and in a controlled manner at a preset rate.
- Normothermia: Lower and upper limits are set to prevent fever. In normothermia mode, if the temperature rises above the target, the device automatically switches to cooling.
Key features
- Servo-controlled automatic mode: Adjusts the water temperature itself to reach and maintain the target temperature.
- Work-to-cool indicator: Shows the clinician when the patient is producing heat (e.g., shivering).
- Institutional protocols: Hospital-specific treatment protocols can be saved so that the same standard is applied on every shift.
- Leak safety: The pads operate under negative pressure; even if a pad is punctured, water does not leak onto the patient or the environment.
- Ease of use: Patient and water temperature, target value and the temperature-time graph are displayed together on the touchscreen; alarms and prompts can be displayed in Turkish.
- Data connectivity: Treatment data are recorded; the temperature graphs of the last 10 patients can be exported via USB.
Areas of use
- Post-cardiac arrest: Hypothermia and fever prevention in general and coronary intensive care.
- Neonatal HIE: Servo-controlled cooling at 33.5 °C for 72 hours in level III neonatal intensive care; neonatal pad from 1.8 kg.
- Pediatric intensive care: Temperature control after cardiac arrest and brain injury; pad options for every body size.
- Neurological and neurosurgical intensive care: Fever control and controlled normothermia in stroke, intracerebral hemorrhage, subarachnoid hemorrhage and traumatic brain injury.
- Cardiovascular surgery: Controlled rewarming of hypothermic patients after surgery at a set rate.
Technical information
- Patient temperature control range: 32–38.5 °C (in 0.1 °C steps)
- Patient temperature measurement accuracy: ±0.2 °C (between 32–38 °C); compatible with YSI 400 series probes
- Circulating water temperature: 4–42 °C, automatically adjusted by servo control
- Controlled rewarming rate: 0.05–0.5 °C per hour
- Water flow rate: 5 L/min · reservoir capacity: 3.5 L
- Heater capacity: 750 W
- Treatment modes: hypothermia (cool, controlled rewarm) and normothermia (control, controlled rewarm)
- Dimensions: 89 × 36 × 47 cm · weight: 43 kg (empty), 47 kg (full)
- Power supply: 220–240 V AC, 50–60 Hz
- Patient groups: adult and pediatric patients of all ages
ArcticGel™ pads
The hydrogel surface of ArcticGel™ pads ensures continuous contact with the skin throughout treatment. Neonatal (1.8–4.5 kg), pediatric and adult pad kits are available; the pad kit is selected according to the patient's weight, and 30–40% of the body surface should be covered with pads. Prizma-Med supplies ArcticGel™ pads throughout Türkiye.
Detailed information by area of use
- Hypothermia system for neonatal HIE
- Targeted temperature management in adult and pediatric patients: emergency, intensive care, neurology, neurosurgery and cardiovascular surgery
- Frequently asked questions about hypothermia treatment (TTM)
Demo, training and service
Prizma-Med provides installation, nurse and physician training, ArcticGel™ pad supply and technical service support. For requests: +90 342 360 64 50 · info@prizmamed.com.tr